Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Phase II/III Trial of Induction Chemotherapy Followed by Continuous Hyperfractionated Accelerated Radiotherapy (CHART) Versus CHART Alone in Patients With Inoperable Non-Small Cell Lung Cancer

NCT00253591 is registered in ClinicalTrials.gov with Medical Research Council as lead sponsor.

NCT NCT00253591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00253591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Phase II/III Trial of Induction Chemotherapy Followed by Continuous Hyperfractionated Accelerated Radiotherapy (CHART) Versus CHART Alone in Patients With Inoperable Non-Small Cell Lung Cancer
Lead sponsor
Medical Research Council
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2005
Completion date
December 31, 2009
Enrollment
500 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer